China-based I-Mab appoints new COO and CMO

China |  News | 0 Comment | 29 Apr, 2022

China's I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization...Read more

Visirna brings RNAi therapeutics for cardiovascular & metabolic diseases in Greater China

China |  News | 0 Comment | 29 Apr, 2022

US-based Arrowhead Pharmaceuticals, Inc. has formed a joint venture, Visirna Therapeutics, with Vivo Capital t...Read more

Hong Kong holds first clinical trial of novel oral treatment for COVID-19

China |  News | 0 Comment | 28 Apr, 2022

The Chinese University of Hong Kong (CUHK)’s Clinical Trial Centre has announced its collaboration with CUHK Medic...Read more

China's Antengene looks to start phase I trial in Australia

China |  News | 0 Comment | 27 Apr, 2022

China's Antengene Corporation, a leading innovative, commercial-stage global biopharmaceutical company dedicated to disc...Read more

Lupin partners with Yabao Pharma for paediatric formulations in China

China |  News | 0 Comment | 27 Apr, 2022

Indian firm Lupin has entered into a strategic partnership with Yabao Pharmaceutical Co, to meet the growing demand for ...Read more

China releases first international COVID-19 testing standard

China |  News | 0 Comment | 26 Apr, 2022

According to the State Administration for Market Regulation in China, the International Organization for Standardization...Read more

Startups accelerate cell therapy development for solid tumours in China

China |  News | 0 Comment | 25 Apr, 2022

China-based startups Suzhou Porton Advanced Solutions and Guizhou Sinorda Biomedicine have announced a long-term strateg...Read more

Wallaby acquires German neurovascular leader Phenox to accelerate global expansion

China |  News | 0 Comment | 22 Apr, 2022

Wallaby Medical, a global innovative medical technology company focused on developing and commercializing neurovascular ...Read more

Lynk Pharmaceuticals gets clinical approval in China for Class I New Drug LNK01004

China |  News | 0 Comment | 22 Apr, 2022

Lynk Pharmaceuticals, an innovative clinical stage company, has announced that its Class I innovative drug LNK01004, has...Read more

ATUM accelerates entry of bioengineering solutions into Chinese pharmaceutical market

China |  News | 0 Comment | 21 Apr, 2022

US-based ATUM has announced a distribution partnership with Trio Biotech to market and promote ATUM’s unique Leap-...Read more

China's ImmVira partners with Roche for cancer therapy

China |  News | 0 Comment | 20 Apr, 2022

China-based startup ImmVira has reached a cooperation agreement with Roche to establish clinical research partnership re...Read more

AmoyDx collaborates with AstraZeneca for multiple companion diagnostics in China

China |  News | 1 Comment | 19 Apr, 2022

Amoy Diagnostics, a China based innovative molecular diagnostics company, has entered into a Master Collaboration A...Read more

GeneQuantum and AIMEDBIO collaborate on a first-in-class antibody drug conjugate

China |  News | 0 Comment | 19 Apr, 2022

China's GeneQuantum Healthcare, a company specializing in site-specific bioconjugation for next generation biotherapeuti...Read more

VectorBuilder invests $500 M in gene delivery research & manufacturing campus in China

China |  News | 0 Comment | 18 Apr, 2022

US-based VectorBuilder Inc. has announced the construction of a new R&D and manufacturing centre in Guangzhou, China...Read more

China's SonoScape receives FDA 510(k) clearance for HD-550 Endoscopy system

China |  News | 0 Comment | 18 Apr, 2022

SonoScape announced that the U.S. Food and Drug Administration (FDA) has approved its flagship video endoscopy system HD...Read more

China approves Fosun Diagnostics' COVID-19 antigen detection kit

China |  News | 0 Comment | 15 Apr, 2022

Shanghai Fosun Pharmaceutical (Group) has announced that the novel coronavirus (2019-nCoV) antigen detection kit (Colloi...Read more

Hong Kong develops portable nucleic acid testing device for COVID-19

China |  News | 0 Comment | 14 Apr, 2022

In 2020, an interdisciplinary research team from The Hong Kong Polytechnic University (PolyU) was awarded over HK$2.7 mi...Read more

Harbour BioMed appoints Dr Humphrey Gardner as Chief Medical Officer

China |  News | 0 Comment | 14 Apr, 2022

Harbour BioMed has announced the appointment of Dr Humphrey Gardner as Chief Medical Officer (CMO). Dr Gardner...Read more